Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.90
Bid: 7.80
Ask: 8.00
Change: -0.15 (-1.86%)
Spread: 0.20 (2.564%)
Open: 8.05
High: 8.05
Low: 7.90
Prev. Close: 8.05
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Company Update

12 Dec 2019 07:00

RNS Number : 5776W
Tekcapital plc
12 December 2019
 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

12 December 2019

Tekcapital Plc

("Tekcapital", the "Company" or "the Group")

Portfolio Company Update:

 

Salarius Secures National Food Ingredient Broker for MicroSalt® 

 

Tekcapital Plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from investing in university technology, is very pleased to announce that its 97.5 per cent. owned portfolio company, Salarius Ltd, has secured an agreement with a national food ingredient broker, Accurate Ingredients, Inc. ("Accurate Ingredients") to market Microsalt® in the United States.

 

MicroSalt® is a proprietary salt, made with micron-size salt particles that dissolve in the mouth significantly faster than regular salt, delivering an increased sensation of saltiness with much less salt, and as a result, approximately 50% less sodium. MicroSalt is Non-GMO, all Natural, Kosher and Gluten Free.

 

The agreement with Accurate Ingredients compliments Salarius existing sales strategy which includes attendance at food trade shows and direct B2B customer outreach initiatives. As of today, over 20 new potential customers are in the process of testing and evaluating the applicability of Microsalt® on their products.

 

"We are very excited about our collaboration with Accurate Ingredients and working with their experienced and highly trained team to accelerate sales and to raise the profile on our value proposition. Salarius will be working with the Accurate Ingredient team in several geographic areas across the U.S." says Victor Hugo Manzanilla, CEO of Salarius.

 

Accurate Ingredients provides a network of experienced sales representatives residing across the United States with offices located on both the east and the west coast, who specialize in the sale of food ingredients. The portfolio of ingredients they sell are used in all segments of the food industry. Their broad range of ingredients can be found in dry, refrigerated and frozen foods.

 

"For over three decades, Accurate ingredients has been a primary resource for proven and reliable food ingredients, and we are pleased to be working with them" says Victor Hugo Manzanilla.

 

 

 

Market Information

The low sodium ingredient market is estimated to reach US$1.76 billion by 2025 with a CAGR 11.7%1. The highly competitive global savory snacks market is expected to reach US$108 billion by 20212.

 

Dr Clifford Gross, Executive Chairman at Tekcapital, commented: "We are glad to see the expansion of Salarius' go to market effort to several important geographical markets in the United States with its first national food ingredient broker."

 

 

 

About Salarius ltd

Salarius, is the developer and manufacturer of a proprietary low sodium salt called MicroSalt®. Salarius is passionate about improving lives with healthier food and is taking the lead in the industry by providing the best low-sodium salt solution, based on the mechanical transformation of the salt particle itself. This solution is the only one that delivers real salt flavor, because it is salt. The technology produces salt crystals that are approximately one hundred times smaller than typical table salt, delivering a powerful saltiness as the micro-grains dissolve in the mouth, with approximately 50% less sodium consumption. Additionally, the ultra-small particle size enhances product adhesion, which reduces waste and provides enhanced flavor consistency. To learn more please visit https://salarius.co/.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed intellectual properties and provides a range of IP investment services to make it easy for organisations to commercialise university-developed technology. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

 

Tekcapital Plc 

 

+1 305-200-3450 

Clifford M. Gross, Ph.D. 

 

 

 

 

 

SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)

 

+44 (0) 20 3470 0470 

Richard Morrison/Charlie Bouverat (Corporate Finance)

 

 

 

 

 

Novum Securities Limited (Joint Broker) 

 

+44 (0) 20 7399 9427

Colin Rowbury (Corporate Broking) 

 

 

 

 

 

 

 

 

 

 

 

 

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Salarius that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Salarius' management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Salarius may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Salarius neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

 

 

 

 

References

 

1 https://www.futuremarketinsights.com/reports/sodium-reduction-ingredient-market

2 https://zmrindustryjournal.us/8402/savory-snacks-market-size-share-expanding-across-the-globe-by-2016-2024/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGGQCPUPBGQG
Date   Source Headline
18th Aug 20227:00 amRNSLucyd Portfolio Company Update
18th Aug 20227:00 amRNSInnovative Eyewear Inc. Closing of US $ 7.35 M IPO
15th Aug 20227:00 amRNSLucyd -Pricing of US$ 7.35 Million IPO
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSHalf Year Report for period ending 31 May 2022
21st Jul 20224:40 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20224:41 pmRNSSecond Price Monitoring Extn
4th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSSalarius First U.S.A. Bulk B2B Order
16th Jun 20229:55 amRNSGrant of Share Options
15th Jun 20222:42 pmRNSNotification of Major Holdings
7th Jun 20227:00 amRNSNotification of Major Holdings
1st Jun 20223:08 pmRNSNotification of Major Holdings
31st May 20222:30 pmRNSResult of AGM
30th May 20227:00 amRNSPortfolio Company Update :Salarius
25th May 20221:19 pmRNSTR-1: Notification of major holdings
25th May 20227:00 amRNSPlacing to Raise £2 Million (c.US$ 2.5M)
6th May 202211:36 amRNSNotice of AGM
6th May 20227:00 amRNSFinal Year End Record Results
5th May 20227:00 amRNSGuident Update
3rd May 20228:35 amRNSGuident Update
19th Apr 20227:00 amRNSPortfolio Company Update - Guident
1st Apr 20227:00 amRNSPortfolio Company Update - Salarius
25th Mar 202211:39 amRNSNotification of Major Holdings
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSSalarius Update
11th Feb 20225:58 pmRNSExercise of Stock Options and Total Voting Rights
11th Feb 20222:06 pmRNSSecond Price Monitoring Extn
11th Feb 20222:00 pmRNSPrice Monitoring Extension
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:01 amRNSPrice Monitoring Extension
4th Feb 20227:00 amRNSGuident Update
2nd Feb 20227:00 amRNSLucyd Expands Ecommerce Channels
4th Jan 20227:00 amRNSSalarius Completes Oversubscribed Crowdfund
29th Dec 20217:00 amRNSSalarius Appoints CEO
24th Dec 20217:00 amRNSSalarius Appoints Non Executive Director
14th Dec 20217:00 amRNSLucyd Filing for United States IPO
9th Dec 20217:00 amRNSSalarius Update
22nd Nov 202112:09 pmRNSHolding(s) in Company
16th Nov 20217:00 amRNSSalarius Update
15th Nov 20217:00 amRNSSalarius Update
11th Nov 20217:00 amRNSAppointment of new Auditor
4th Nov 20217:00 amRNSPortfolio Company Update: Lucyd Ltd ("Lucyd")
3rd Nov 20217:00 amRNSPlacing to raise £3.0 million
27th Oct 20217:00 amRNSSalarius Appointment of Chief Medical Officer
26th Oct 20214:40 pmRNSSecond Price Monitoring Extn
26th Oct 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.